Antimicrobial therapy to prevent or treat oral mucositis (Q35167422)

6 August 2017

1 reference

title

Antimicrobial therapy to prevent or treat oral mucositis (English)

1 reference

6 August 2017

1 reference

J Peter Donnelly

1 reference

6 August 2017

Lisa A Bellm

1 reference

6 August 2017

Joel B Epstein

1 reference

6 August 2017

Stephen T Sonis

1 reference

6 August 2017

R Paul Symonds

1 reference

6 August 2017

publication date

1 July 2003

1 reference

Lancet Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

405-412

1 reference

Oral mucositis in myelosuppressive cancer therapy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Research controversies in management of oral mucositis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Modifications of the microflora of the oral cavity arising during immunosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Oral sources of septicaemia in patients with malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

The relationships among fluoride, cariogenic oral flora, and salivary flow rate during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Oral infections and septicemia in immunocompromised patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

The oral flor as a source of septicemia in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Bacteremia due to viridans streptococci in neutropenic patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Risk Factors for Anaerobic Bloodstream Infections in Bone Marrow Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Prevalence of gram-negative rods in the normal pharyngeal flora

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Do microorganisms play a role in irradiation mucositis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Protegrins: new antibiotics of mammalian origin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Epithelial antimicrobial peptides: review and significance for oral applications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Epithelial antimicrobial peptides in host defense against infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Cytokine responses during mucosal infections: role in disease pathogenesis and host defence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Radiation mucositis: a new approach to prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Incidence of oral complications and application of a preventive protocol in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Symptomatic acute mucositis can be minimized or prophylaxed by the combination of sucralfate and fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

A double-blind, placebo-controlled, randomized trial to evaluate the role of tetrachlorodecaoxide in the management of chemotherapy-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Mucosa-adhesive water-soluble polymer film for treatment of acute radiation-induced oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Palliation of radiation-related mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Mucositis associated with stem cell transplantation: current status and innovative approaches to management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900668-6

7 January 2021

10.1016/S1473-3099(03)00668-6

Identifiers

DOI

1 reference

6 August 2017

1 reference